People with congenital stationary night blindness (CSNB) are unable to distinguish objects in dim-light conditions. This impairment presents challenges, especially where artificial lighting is unavailable or when driving at night.
More than half of people with diabetes will develop diabetic retinopathy, one of the leading causes of legal blindness in the U.S., yet fewer than half of patients with diabetes get their annual screenings.
Like flocks of birds or schools of fish, crowds of humans also tend to move en masse — almost as if they’re thinking as one. Scientists have proposed different theories to explain this type of collective pedestrian behavior.
Researchers have uncovered new information about how the area of the brain responsible for memory is triggered when the eyes come to rest on a face versus another object or image.
Bilal Haider is studying how multiple areas of the brain work together for visual perception. This could help researchers understand if neural activity “traffic jams” underlie all kinds of visual impairments: from running a red light when visual attention is elsewhere, to shedding light on the autism-affected brain.
Don't miss these articles in our Staff Picks channel
Glaucoma Research Foundation (GRF) today announced a total of $1.3 million in annual research grants to support 10 investigators at prominent universities across the United States.
Glaucoma Research Foundation, the nation’s most experienced foundation dedicated solely to glaucoma research and education, recently elected Oluwatosin “Tosin” Smith, MD to its Board of Directors.
The Association for Research in Vision and Ophthalmology (ARVO) announced today that Robert P. Finger, MD, MIH, PhD, of the University of Bonn, Germany, is the 2022 recipient of the Ludwig Von Sallmann Clinician-Scientist Award.
A recent study published in Current Eye Research evaluated seven studies looking at the relationship between alcohol consumption and AMD. The researchers found that moderate to high alcohol consumption was linked to a higher incidence of early AMD, compared with people who didn’t drink or who drank occasionally.
A new dataset released by a New York University Tandon School of Engineering research team and Woven Planet Holdings, Inc., a Toyota subsidiary dedicated to building the safest mobility in the world, promises to help visually impaired pedestrians and autonomous vehicles (AVs) alike better navigate complex urban settings.
A team led by researchers from the University of Waterloo discovered that a significant increase in tear secretion and tear film stability after participating in aerobic exercise can be another remedy for relieving dry, itchy eyes.
During February’s AMD Awareness Month, America’s retina specialists urge everyone to pay special attention to their vision, learn more about AMD, and understand the ABCs of AMD symptoms which warrant an immediate visit with a retina specialist for a comprehensive dilated retina exam.
Neuroscientists at the David Geffen School of Medicine at UCLA in collaboration with scientists at UC Berkeley have discovered that visual stimulation not only guides the way brain cells connect, but actually influences the types of cells that form in the first place – something that was thought to be genetically programmed.
Glaucoma Research Foundation (GRF) will host the 11th Annual Glaucoma 360 New Horizons Forum on February 11th at the Grand Hyatt Union Square in San Francisco. Offered both in person and virtually, this important meeting brings together leaders in glaucoma research and industry to speed the translation of new ideas to improved treatments for glaucoma patients.
Ronald L. Fellman, MD, David Calkins, PhD, and Steven and Michele Kirsch will be honored at the Glaucoma Research Foundation's Annual Gala on February 10, 2022.
David Calkins, PhD, a leading authority on the neurobiological basis of vision loss in blinding eye disease, will be honored at the Glaucoma 360 Annual Gala on February 10, 2022.
Can mindfulness meditation help patients with glaucoma? A recent study suggests that there may be benefits to eye pressure and optic nerve health by doing meditation on a regular basis.
Irvine, Calif., Jan. 26, 2022 — Researchers from the University of California, Irvine have discovered that the absence of Adiponectin receptor 1 protein (AdipoR1), one of the principal enzymes regulating ceramide homeostasis in the retina, leads to an accumulation of ceramides in the retina, resulting in progressive photoreceptor cell death and ultimately vision loss.
The American Academy of Ophthalmology today announced the appointment of Russell N. Van Gelder, MD, PhD, as Editor-in-Chief of its flagship journal, Ophthalmology, the most widely read clinical publication within the medical specialty of ophthalmology.
Scientists have developed an artificial intelligence (AI) system that can analyse eye scans taken during a routine visit to an optician or eye clinic and identify patients at a high risk of a heart attack.
National Eye Institute researchers developed and validated an artificial-intelligence-based method to evaluate patients with Stargardt, an eye disease that can lead to childhood vision loss. The method quantifies disease-related loss of light-sensing retina cells, yielding information for monitoring patients, understanding genetic causes of the disease, and developing therapies to treat it.
-rgb300-(1)-for-web-page.jpg&width=400&height=400)
A patented biomaterial developed by South Dakota State University associate professor Gudiseva Chandrasekher has the potential to repair corneal damage and to create corneal implants.
Both supermodel Christie Brinkley and Bono, the lead singer of U2, were diagnosed with glaucoma during a routine eye exam. Both were also surprised by the diagnosis since they weren’t experiencing problems with their vision.
Ending inequities in healthcare will require teamwork. That’s why the American Academy of Ophthalmology and Prevent Blindness teamed up to launch the Children’s Vision Equity Alliance (CVEA).
The Association for Research in Vision and Ophthalmology (ARVO) congratulates the inaugural winners of the Point of View Award: Dasha Nelidova, MBChB, PhD and Botond Roska, MD, PhD. The award recognizes significant research that may advance the ability to restore sight.
Scientists at St. Jude Children’s Research Hospital identified distinct functions for regions of a super-enhancer that controls gene expression during retina formation, calling it a ‘modular’ super-enhancer.
A Florida State University technology developed to treat an incurable eye condition has proven so effective in clinical trials that investors have funded a third portion of Series A financing for Trefoil Therapeutics to support the further creation of treatments for corneal disease.
The Association for Research in Vision and Ophthalmology (ARVO) congratulates Cammi Valdez, PhD, the 2022 recipient of the Genentech Career Development Award for Underrepresented Minority (URM) Emerging Vision Scientists.
The Association for Research in Vision and Ophthalmology (ARVO) today announced Paulo J. M. Bispo, MS, PhD, of Massachusetts Eye and Ear, Harvard Medical School is the 2022 recipient of the Mallinckrodt Uveitis Research Fellowship.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipients of the Pfizer Ophthalmics Carl Camras Translational Research Award. The 2022 awardees are: - PremNandhini Satgunam, BS(Opt), MS, PhD, LV Prasad Eye Institute, Hyderabad, Telangana, India - Jee Myung Yang, MD, PhD, Asan Medical Center, Seoul, South Korea
Robert E. Wiggins Jr., MD, MHA, this week begins his one-year term as the 126th president of the American Academy of Ophthalmology.
January, National Glaucoma Awareness Month, is an excellent time to get a comprehensive dilated eye exam—the most effective way to test for glaucoma—and to convince your loved ones to get tested, too.
The Association for Research in Vision and Ophthalmology (ARVO) congratulates Rajeev H. Muni, MD, the first recipient of the Kreissig Award for Excellence in Retinal Surgery. Established by Ingrid Kreissig, MD, through the ARVO Foundation, the $30,000 award recognizes an investigator who has developed clinical insights into the long-term surgical and functional outcomes after retinal detachment repair.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the 2022 recipients of the ARVO Foundation Collaborative Research Fellowship: Ali Al-Timemy, PhD; Shikha Gupta, MD; Diana Pérez-Ibave, PhD. Fellows receive a $10,000 award to support a one-year project.
For the first time, University of California, Irvine researchers in collaboration with the Max-Planck Institute of Biochemistry, have revealed, at a molecular level, key structural determinants of the highly specialized rod outer segment (ROS) membrane architecture of the eye, which is instrumental to vision.
January, National Glaucoma Awareness Month, is an excellent time to focus on eye health.
Marking its 30th anniversary and her enduring interest and support, philanthropist Darlene Shiley has given a $10 million gift for the clinical space expansion of the Shiley Eye Institute at UC San Diego Health.
Stuart Therapeutics, Inc. (STUART), a clinical stage, innovative ophthalmic therapeutic development company, today announced the topline results of the first in human Phase 2 clinical trial for its lead drug candidate, ST-100 in patients with dry eye disease.
The Association for Research in Vision and Ophthalmology (ARVO) today announced Joanne Wood, PhD, is the 2022 recipient of the Oberdorfer Award in Low Vision Research. Wood's body of research has made a significant contribution to health practice and policy, including advice to licensing bodies and health professionals regarding driver licensing standards, and has been translated into standards.
The Association for Research in Vision and Ophthalmology (ARVO) congratulates Magdalena Renner, MD, recipient of the 2022 Bert M. Glaser, MD Award for Innovative Research in Retina. The award recognizes an early-career investigator who has made a novel discovery that impacted the understanding and/or treatment of a retinal disease or condition.
New research project uses AI strategies to address gaps in glaucoma care.
Nixon Foundation funds effort to study and treat macular dystrophy at Shiley Eye Institute. Currently, there are no effective treatments to slow or prevent genetic condition.
Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment exists. The scientists, from the National Eye Institute (NEI), part of the National Institutes of Health, published their findings today in Nature Communications.
The American Academy of Ophthalmology released a screen-free holiday gift guide focused on healthy kids and healthy eyes.
A subtle smile emerged on Dr. James Leidner’s face as he envisioned telling people of the unusual contribution he made to mankind’s mission to Mars.
Scientists have discovered that gene therapy and the diabetes drug metformin may be potential treatments for late-onset retinal degeneration (L-ORD), a rare, blinding eye disease. Researchers from the National Eye Institute (NEI), part of the National Institutes of Health generated a “disease-in-a-dish” model to study the disease. The findings are published in Communications Biology.
This news comes at a time of increased COVID-19 hospitalizations across Loyola Medicine. During the first week of December 2021, thirty-five patients with COVID-19 were admitted to Loyola University Medical Center, an increase of 169% over the same period last month.
Pediatric ophthalmologist with Shiley Eye Institute at UC San Diego Health explains why infantile cataracts are more common — and problematic — than most people realize.
Immune cells could be doing much more than we think in protecting our eyes – Jefferson researchers uncover new details.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
